Wird geladen...
Prognostication with circulating tumor DNA: is it ready for prime time?
Emerging methods to detect tumor-derived DNA in the blood plasma of patients with lymphomas—so-called “circulating tumor DNA” (ctDNA)—have the potential to change the way in which lymphoma is diagnosed and managed in the clinic. The possible applications for ctDNA are numerous, including mutation ge...
Gespeichert in:
| Veröffentlicht in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Hematology
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913479/ https://ncbi.nlm.nih.gov/pubmed/31808836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000013 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|